Cite
HARVARD Citation
Meyers, J. et al. (2017). Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Human vaccines & immunotherapeutics. 13 (8), pp. 1861-1872. [Online].